SkyCell

PharmaLifeScience News

...

Andrew Witty steps down as UnitedHealth CEO
Witty’s departure was unexpected, but follows a downturn in the healthcare company’s financial outlook. He will be replaced by Stephen Hemsley, chair of UnitedHealth’s board.
READ MORE
...

SETU to advance ocular disease research with €3.1m funding
SETU is the first Irish technological university to coordinate a Horizon Europe Marie Skłodowska-Curie cofund programme.Read more: SETU to advance ocular disease research with €3.1m funding
READ MORE
...

GSK buys Boston Pharmaceutical’s new liver disease drug for up to $2bn
Deal targets conditions that cost US health system billions annually
READ MORE

Solgate Streamlines SLC Drug Discovery with INTEGRA’s Automated Pipetting Systems

World-first approval supports AstraZeneca’s sustainability goals

Scientists Use AI to Predict Future Viruses and Design Better Vaccines

Roche plans $700m manufacturing plant in the US

Trump vows to lower drug prices in the US by up to 80%

LENZ and Lotus Pharmaceutical collaborate to commercialise presbyopia treatment

AI-powered drug discovery is outpacing regulators, with Eric Luellen

Optimizing Clinical Trials with Precision Medicine: A Candid Expert Discussion

Bluebird extends deal deadline; Affimed files for insolvency

GSK and iTeos drop anti-TIGIT drug following trial failure

Key Factors in Selecting a Patient Support Model Approach

Johnson & Johnson’s bladder cancer therapy Balversa accepted by SMC

Tozaro forms Technical Advisory Board to accelerate Smart Polymer commercialisation for CGT bioprocessing

Novo makes fresh obesity play with $2.2bn Septerna deal

Viral circRNAs Sponge Up Host miRNAs to Weaken Immune Response

GSK pays $1.2bn for liver drug as it culls TIGIT programme

Bristol Myers Squibb appoints Cari Gallman as executive vice president, general counsel and chief policy officer

GSK to buy liver disease drug for $1.2B

GSK to expand hepatology pipeline with potential best-in-class therapy

Physical function before treatment predicts response to daratumumab in multiple myeloma

Air travel disrupts DNA repair in flight crew, raising cancer concerns
Ellab